chr15-89776424-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001039958.2(MESP2):c.67G>A(p.Gly23Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,533,216 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G23G) has been classified as Likely benign.
Frequency
Consequence
NM_001039958.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MESP2 | NM_001039958.2 | c.67G>A | p.Gly23Ser | missense_variant | 1/2 | ENST00000341735.5 | |
LOC124903550 | XR_007064751.1 | n.186C>T | non_coding_transcript_exon_variant | 1/2 | |||
LOC124903550 | XR_007064752.1 | n.151C>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MESP2 | ENST00000341735.5 | c.67G>A | p.Gly23Ser | missense_variant | 1/2 | 1 | NM_001039958.2 | P1 | |
MESP2 | ENST00000560219.2 | c.31-1641G>A | intron_variant | 1 | |||||
MESP2 | ENST00000558723.1 | n.39-1641G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152242Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000264 AC: 34AN: 128662Hom.: 0 AF XY: 0.000141 AC XY: 10AN XY: 70720
GnomAD4 exome AF: 0.0000912 AC: 126AN: 1380856Hom.: 0 Cov.: 31 AF XY: 0.0000646 AC XY: 44AN XY: 681528
GnomAD4 genome AF: 0.000919 AC: 140AN: 152360Hom.: 1 Cov.: 33 AF XY: 0.00101 AC XY: 75AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spondylocostal dysostosis 2, autosomal recessive Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 30, 2020 | - - |
MESP2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at